130 related articles for article (PubMed ID: 38345243)
1. Integrated plasma proteomics and N-glycoproteomics reveals alterations in the N-glycosylation in Chinese hepatocellular carcinoma patients.
Zeng J; Rong W; Meng B; Zheng L; Peng T; Zhai R; Jiang Y; Xiao T; Fang X; Zhang Y; Zhao Y; Dai X
Proteomics Clin Appl; 2024 Feb; ():e2300029. PubMed ID: 38345243
[TBL] [Abstract][Full Text] [Related]
2. Glycoproteomic contributions to hepatocellular carcinoma research: a 2023 update.
Zheng Y; Gao K; Gao Q; Zhang S
Expert Rev Proteomics; 2023; 20(10):211-220. PubMed ID: 37882248
[TBL] [Abstract][Full Text] [Related]
3. [Recent advances in glycopeptide enrichment and mass spectrometry data interpretation approaches for glycoproteomics analyses].
Liu L; Qin H; Ye M
Se Pu; 2021 Oct; 39(10):1045-1054. PubMed ID: 34505426
[TBL] [Abstract][Full Text] [Related]
4. Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer.
Nigjeh EN; Chen R; Allen-Tamura Y; Brand RE; Brentnall TA; Pan S
Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28627758
[TBL] [Abstract][Full Text] [Related]
5. An Integrated Proteomic and Glycoproteomic Investigation Reveals Alterations in the
Ma C; Tsai HY; Zhang Q; Senavirathna L; Li L; Chin LS; Chen R; Pan S
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897829
[TBL] [Abstract][Full Text] [Related]
6. GPSeeker Enables Quantitative Structural N-Glycoproteomics for Site- and Structure-Specific Characterization of Differentially Expressed N-Glycosylation in Hepatocellular Carcinoma.
Xiao K; Tian Z
J Proteome Res; 2019 Jul; 18(7):2885-2895. PubMed ID: 31117584
[TBL] [Abstract][Full Text] [Related]
7. An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors.
Li QK; Shah P; Tian Y; Hu Y; Roden RBS; Zhang H; Chan DW
Clin Proteomics; 2017; 14():16. PubMed ID: 28491011
[TBL] [Abstract][Full Text] [Related]
8. Identification of N-glycosylation in hepatocellular carcinoma patients' serum with a comparative proteomic approach.
Huang Y; Wu H; Xue R; Liu T; Dong L; Yao J; Zhang Y; Shen X
PLoS One; 2013; 8(10):e77161. PubMed ID: 24143209
[TBL] [Abstract][Full Text] [Related]
9. Lectin-based glycoproteomics to explore and analyze hepatocellular carcinoma-related glycoprotein markers.
Dai Z; Zhou J; Qiu SJ; Liu YK; Fan J
Electrophoresis; 2009 Sep; 30(17):2957-2966. PubMed ID: 19711376
[TBL] [Abstract][Full Text] [Related]
10. Identification of Dysregulated Complement Activation Pathways Driven by N-Glycosylation Alterations in T2D Patients.
Zhao Y; Wang M; Meng B; Gao Y; Xue Z; He M; Jiang Y; Dai X; Yan D; Fang X
Front Chem; 2021; 9():677621. PubMed ID: 34178943
[TBL] [Abstract][Full Text] [Related]
11. Plasma glycoproteomics delivers high-specificity disease biomarkers by detecting site-specific glycosylation abnormalities.
Wessels HJCT; Kulkarni P; van Dael M; Suppers A; Willems E; Zijlstra F; Kragt E; Gloerich J; Schmit PO; Pengelley S; Marx K; van Gool AJ; Lefeber DJ
J Adv Res; 2023 Sep; ():. PubMed ID: 37683725
[TBL] [Abstract][Full Text] [Related]
12. An N-glycoproteomic site-mapping analysis reveals glycoprotein alterations in esophageal squamous cell carcinoma.
Gao Y; Shen L; Dong T; Yang X; Cui H; Guo Y; Ma Y; Kong P; Cheng X; Zhang L; Cui Y
J Transl Med; 2022 Jun; 20(1):285. PubMed ID: 35752862
[TBL] [Abstract][Full Text] [Related]
13. Integrated glycoproteomic characterization of clear cell renal cell carcinoma.
Lih TM; Cho KC; Schnaubelt M; Hu Y; Zhang H
Cell Rep; 2023 May; 42(5):112409. PubMed ID: 37074911
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma.
Kohansal-Nodehi M; Swiatek-de Lange M; Kroeniger K; Rolny V; Tabarés G; Piratvisuth T; Tanwandee T; Thongsawat S; Sukeepaisarnjaroen W; Esteban JI; Bes M; Köhler B; Chan HL; Busskamp H
Front Oncol; 2023; 13():1213898. PubMed ID: 37920152
[TBL] [Abstract][Full Text] [Related]
15. Integrated Proteomic and N-Glycoproteomic Profiling of Placental Tissues of Patients with Preeclampsia.
Wang H; Shi Y; Ma J; Wang W; Gao J; Zhao L; Zhao T; Ding G
Int J Womens Health; 2023; 15():59-68. PubMed ID: 36660462
[TBL] [Abstract][Full Text] [Related]
16. Urinary glycoproteomic profiling of non-muscle invasive and muscle invasive bladder carcinoma patients reveals distinct N-glycosylation pattern of CD44, MGAM, and GINM1.
Sathe G; George IA; Deb B; Jain AP; Patel K; Nayak B; Karmakar S; Seth A; Pandey A; Kumar P
Oncotarget; 2020 Aug; 11(34):3244-3255. PubMed ID: 32922663
[TBL] [Abstract][Full Text] [Related]
17. Glycoproteomic Analysis of Urinary Extracellular Vesicles for Biomarkers of Hepatocellular Carcinoma.
Li D; Jia S; Wang S; Hu L
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770959
[TBL] [Abstract][Full Text] [Related]
18. MRM validation of targeted nonglycosylated peptides from N-glycoprotein biomarkers using direct trypsin digestion of undepleted human plasma.
Lee JY; Kim JY; Cheon MH; Park GW; Ahn YH; Moon MH; Yoo JS
J Proteomics; 2014 Feb; 98():206-17. PubMed ID: 24434586
[TBL] [Abstract][Full Text] [Related]
19. Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.
Pan S; Chen R; Tamura Y; Crispin DA; Lai LA; May DH; McIntosh MW; Goodlett DR; Brentnall TA
J Proteome Res; 2014 Mar; 13(3):1293-306. PubMed ID: 24471499
[TBL] [Abstract][Full Text] [Related]
20. Serum Glycoprotein Markers in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
Ramachandran P; Xu G; Huang HH; Rice R; Zhou B; Lindpaintner K; Serie D
J Proteome Res; 2022 Apr; 21(4):1083-1094. PubMed ID: 35286803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
